Open access peer-reviewed Edited Volume

Radiopharmaceuticals

Farid A. Badria

Mansoura University

Prof. Farid Badria has utilized his extensive experience to develop therapeutic agents and drugs for schistosomiasis, hepatitis, and alopecia. Dr. Badria is the holder of 20 patents (Spirooxindoles As MDM2 P53 inhibitor for liver cancer), 250 publications, and more than a dozen books (H-index 33). He is a member of the AAAS, the ASP, and the New York Academy of Science. He is cited by the Stanford University list among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry.

Covering

Radioactive Drugs Diagnosis Therapeutics Nuclear Medicine Cancer Pain Management Biodistribution Radionuclides Nanoparticles VMAT Nanotechnology Modes of Action

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Radiopharmaceuticals are special medicinal preparations containing radioisotopes which are used in many clinical areas for either diagnosis and/or therapy.

This book intends to provide the reader with a comprehensive overview of the current state-of-the-art in nuclear medicine's safety, featuring an easy-to-follow, vignette-based format that focuses on the most important evidence-based developments in tradiopharmaceuticals as important area in cancer therapy, bone metastasis, and neuroendocrinology tumours.

This book will aim to present the different methods for preparation, products evaluation, pharmacokinetics, biodistribution, and dose calculations. Moreover, new approaches will be discussed for new possible uses in both diagnosis and treatment to lessen the possible hazardous side effects. Basic, practical, and clinical applications will be presented in an easy and applied manner.

Interestingly, new techniques and new applications will be addresses especially in the area of the development of monoclonal antibodies (MoAbs) in radioscintigraphy of tumors. The use of nanostechnology enhance the efficacy of radiopharmaceuticals and improve the selectivity and pharmacokinetic properties.

Publishing process

Book initiated and editor appointed

Date completed: March 9th 2021

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: June 5th 2021

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: August 24th 2021

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: October 23rd 2021

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Farid A. Badria

Mansoura University

Professor Farid Badria, Ph.D., MSc, is the recipient of several awards including The World Academy of Sciences (TWAS) Prize for Public Understanding of Science; World Intellectual Property Organization (WIPO) Gold Medal for Best Inventor; State Recognition Outstanding Award in Medicine (Egyptian Academy of Science); Outstanding Arab Scholar, Kuwait; and Khawrazmi International Award, Iran. He is also a scholar of the Arab Development Fund, Kuwait; International Cell Research Organization (ICRO)-United Nations Educational, Scientific and Cultural Organization (UNESCO) International, Chile; and UNESCO Biotechnology France. Dr. Badria has 20 patents, 250 publications, more than a dozen books, several marketed pharmaceutical products, and many plenary lectures and workshops to his credit. He continues to lead research projects on developing new therapies for liver disease, skin disorders, and cancer.

View profile

Book chapters authored 2

Books edited 6

Introducing your Author Service Manager

Mr. Mateo Pulko

As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire